PH24494A - Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues - Google Patents

Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues

Info

Publication number
PH24494A
PH24494A PH34110A PH34110A PH24494A PH 24494 A PH24494 A PH 24494A PH 34110 A PH34110 A PH 34110A PH 34110 A PH34110 A PH 34110A PH 24494 A PH24494 A PH 24494A
Authority
PH
Philippines
Prior art keywords
sup
disubstituted
amino
acid residues
hydroxypentanoic acid
Prior art date
Application number
PH34110A
Other languages
English (en)
Inventor
Jasjit Singh Bindra
Edward Fox Kleinman
Robert Louis Rosati
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PH24494A publication Critical patent/PH24494A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/14—Angiotensins: Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polyamides (AREA)
PH34110A 1985-08-09 1986-08-07 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues PH24494A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76416885A 1985-08-09 1985-08-09
US06/858,324 US4729985A (en) 1985-08-09 1986-04-30 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues

Publications (1)

Publication Number Publication Date
PH24494A true PH24494A (en) 1990-07-18

Family

ID=27117410

Family Applications (1)

Application Number Title Priority Date Filing Date
PH34110A PH24494A (en) 1985-08-09 1986-08-07 Renin inhibitors containing 5-amino-2,5-disubstituted-4-hydroxypentanoic acid residues

Country Status (22)

Country Link
US (1) US4729985A (fr)
EP (1) EP0212903B1 (fr)
JP (1) JPS6253952A (fr)
KR (1) KR890003603B1 (fr)
CN (1) CN86105870A (fr)
AT (1) ATE84046T1 (fr)
AU (1) AU576970B2 (fr)
CA (1) CA1294736C (fr)
DE (1) DE3687380T2 (fr)
DK (1) DK379186A (fr)
EG (1) EG17971A (fr)
ES (1) ES2000852A6 (fr)
FI (1) FI86192C (fr)
GR (1) GR862078B (fr)
HU (1) HU207101B (fr)
IE (1) IE58524B1 (fr)
IL (1) IL79626A0 (fr)
NO (1) NO170725C (fr)
NZ (1) NZ217127A (fr)
PH (1) PH24494A (fr)
PT (1) PT83172B (fr)
YU (1) YU45355B (fr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4727060A (en) * 1984-11-13 1988-02-23 Ciba-Geigy Corporation Novel 5-amino-4-hydroxyvaleryl derivatives
DE3538749A1 (de) * 1985-10-31 1987-05-07 Merck Patent Gmbh Peptide
EP0236734A3 (fr) * 1986-02-07 1988-05-11 Ciba-Geigy Ag Dérivés d'amino-5-hydroxy-4-valeryl substitués par des groupes contenant du soufre
DE3626130A1 (de) * 1986-08-01 1988-02-11 Merck Patent Gmbh Aminosaeurederivate
US4681972A (en) * 1986-09-16 1987-07-21 Warner-Lambert Company Separation of diastereomers
US4851387A (en) * 1986-10-14 1989-07-25 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentanoic acid derivatives and their use
US4927565A (en) * 1986-12-19 1990-05-22 Banyu Pharmaceutical Co., Ltd. 5-substituted amino-4-hydroxy-pentenoic acid derivatives and their use
US4758584A (en) * 1987-02-05 1988-07-19 Ciba-Geigy Corporation Antihypertensive 5-amino-4-hydroxyvaleryl derivatives substituted by sulphur-containing groups
DE3888031T2 (de) * 1987-07-01 1994-06-09 Pfizer Homocyclostatin und Cyclostatin enthaltende Polypeptide als Antihypertensiva.
US4859654A (en) * 1987-07-01 1989-08-22 Pfizer Inc. Homocyclostatine and cyclostatine containing polypeptides as antihypertensive agents
EP0312158A3 (fr) * 1987-10-13 1990-07-25 Merck & Co. Inc. Tétrapeptides ayant des composantes d'amides d'acides aminés C-terminales, inhibiteurs de la rénine
GB8728561D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
GB8728560D0 (en) * 1987-12-07 1988-01-13 Glaxo Group Ltd Chemical compounds
ES2058489T3 (es) * 1988-01-26 1994-11-01 Sankyo Co Oligopeptidos con actividades inhibidoras de la renina, su preparacion y su uso.
AU632468B2 (en) * 1988-02-01 1993-01-07 Upjohn Company, The Renin inhibiting peptides with polar end groups
JPS6486550A (en) * 1988-08-19 1989-03-31 Seiko Epson Corp Complementary mos integrated circuit
US5436339A (en) * 1991-03-06 1995-07-25 Abbott Laboratories Process for the preparation of a substituted diaminoalcohol
US5238935A (en) * 1991-05-20 1993-08-24 Schering Corporation N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme A: cholesterol acyl transferase
US5124337A (en) * 1991-05-20 1992-06-23 Schering Corporation N-acyl-tetrahydroisoquinolines as inhibitors of acyl-coenzyme a:cholesterol acyl transferase
TW217410B (fr) * 1992-04-01 1993-12-11 Ciba Geigy
MY119161A (en) * 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
EP0702004A2 (fr) * 1994-09-15 1996-03-20 Ciba-Geigy Ag Dérivés d'amides d'acide 2,9-diamino- et 2-amino-2-carbamoyl-4-hydroxy-alcanoiques
EP0716077A1 (fr) * 1994-12-08 1996-06-12 Ciba-Geigy Ag Amides d'acides oméga-amino alcanoiques et diamides alcanoiques ayant un substituant aromatique et leur application en tant qu'inhibiteurs de leur rénine
CA2191924A1 (fr) * 1995-12-05 1997-06-06 Kevin Felsenstein Derives de 5-amino-6-cyclohexyl-4-hydroxyhexanamide, inhibiteurs de la production de proteine .beta.-amyloide
US5703129A (en) * 1996-09-30 1997-12-30 Bristol-Myers Squibb Company 5-amino-6-cyclohexyl-4-hydroxy-hexanamide derivatives as inhibitors of β-amyloid protein production
DE60124080T2 (de) 2000-03-23 2007-03-01 Elan Pharmaceuticals, Inc., San Francisco Verbindungen und verfahren zur behandlung der alzheimerschen krankheit
CN1217920C (zh) 2000-06-30 2005-09-07 艾兰制药公司 治疗早老性痴呆的化合物
US8779198B2 (en) * 2009-08-11 2014-07-15 Novartis Ag Ring opening of lactones and lactams
CN105195868B (zh) * 2015-11-12 2018-05-15 上海电气核电设备有限公司 一种机器人焊接系统及其焊接方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4163676A (en) * 1978-04-03 1979-08-07 Blue Cross Laboratories Ethanol-modified lecithin cookware spray composition
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
CA1258748A (fr) * 1981-10-08 1989-08-22 Daniel F. Veber Peptides inhibiteurs de la renine
US4478826A (en) * 1981-10-08 1984-10-23 Merck & Co., Inc. Renin inhibitory peptides
US4470971A (en) 1981-10-19 1984-09-11 Merck & Co., Inc. Renin inhibitory peptides having His13
US4397786A (en) 1981-11-23 1983-08-09 Merck & Co., Inc. Method of preparing statine and derivatives
CA1245217A (fr) * 1981-12-10 1988-11-22 Joshua S. Boger Peptides inhibiteurs de la renine
WO1984003044A1 (fr) * 1983-02-07 1984-08-16 Ferring Ab Inhibiteurs enzymatiques
US4613676A (en) * 1983-11-23 1986-09-23 Ciba-Geigy Corporation Substituted 5-amino-4-hydroxyvaleryl derivatives
DK110285A (da) * 1984-03-12 1985-09-13 Pfizer Polypeptider og polypeptidderivater indeholdende statin eller derivater deraf og farmaceutiske praeparater
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
DK356085A (da) * 1984-08-06 1986-02-07 Upjohn Co Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
DE3512128A1 (de) * 1985-04-03 1986-10-09 Merck Patent Gmbh, 6100 Darmstadt Peptide

Also Published As

Publication number Publication date
KR890003603B1 (ko) 1989-09-27
GR862078B (en) 1986-12-24
EP0212903A3 (en) 1989-11-15
DE3687380T2 (de) 1993-04-29
ATE84046T1 (de) 1993-01-15
YU45355B (en) 1992-05-28
EP0212903A2 (fr) 1987-03-04
IE862143L (en) 1987-02-09
NO170725C (no) 1992-11-25
DK379186A (da) 1987-04-01
PT83172B (pt) 1989-03-30
FI863250A0 (fi) 1986-08-08
EG17971A (en) 1991-11-30
FI86192C (fi) 1992-07-27
CN86105870A (zh) 1987-03-11
AU576970B2 (en) 1988-09-08
YU142286A (en) 1988-10-31
US4729985A (en) 1988-03-08
JPH0543697B2 (fr) 1993-07-02
NO863202D0 (no) 1986-08-08
NO170725B (no) 1992-08-17
EP0212903B1 (fr) 1992-12-30
NZ217127A (en) 1989-11-28
PT83172A (en) 1986-09-01
AU6102186A (en) 1987-02-12
KR870002164A (ko) 1987-03-30
ES2000852A6 (es) 1988-03-16
IL79626A0 (en) 1986-11-30
HU207101B (en) 1993-03-01
DE3687380D1 (de) 1993-02-11
FI863250A (fi) 1987-02-10
DK379186D0 (da) 1986-08-08
CA1294736C (fr) 1992-01-21
JPS6253952A (ja) 1987-03-09
IE58524B1 (en) 1993-10-06
FI86192B (fi) 1992-04-15
HUT41419A (en) 1987-04-28
NO863202L (no) 1987-02-10

Similar Documents

Publication Publication Date Title
AU576970B2 (en) Renin inhibitors containing 5-amino-2, 5-disubstituted-4- hydroxypentanoic acid residues
MA18664A1 (fr) Derives d'amino-acides utiles comme agents contre l'hypertension
AU6049696A (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
ATE14882T1 (de) Amino- und substituierte amino-phosphinylalkanoyl-zubereitungen.
MX9304970A (es) ACIDOS ß-AMINOALQUIL- Y ß-N-PEPTIDILAMINOALQUIL-BORONICOS.
EP0310073A3 (fr) Bêta-amino-acyl aminodiolcarbamates non peptidiques comme agents antihypertensifs
ES8706167A1 (es) Un procedimiento para preparar nuevos peptidos hipotensivos.
EP0310072A3 (fr) Bêta-succinamidoacyl aminodiols non peptidiques comme agents anti-hypertensifs
EP0296581A3 (fr) Dérivés 1,2-dicéto amino-acides comme inhibiteurs de la rénine
EP0313847A3 (fr) Alpha-succinamidoacyl aminodiols non peptidiques comme agents anti-hypertensifs
ES2002469A6 (es) Un procedimiento para la preparacion de nuevos di -.tri -. y tetrapeptidos inhibidores de renina.
FR2575164B1 (fr) Esters de tri- et tetrapeptides inhibiteurs de la secretion gastrique, procede d'obtention et compositions pharmaceutiques les contenant
KR850006941A (ko) 데스-프로린 바조프레신 길항제의 제조방법
EA200100661A1 (ru) Способ получения производных 2-азадигидроксибицикло [2.2.1] гептана
DE3688383D1 (de) Rekombinantes vektorsystem fuer metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
AR004727A1 (es) El uso de un compuesto para la transfeccion de celulas y una composicion
KR910009663A (ko) 피리딘유도체, 이들을 함유하는 약리학적 조성물 및 이들의 제조방법
RU92004529A (ru) Производные 2-азабицикло /2,2,1/гепт-5-ен-2-уксусной кислоты
ATE69806T1 (de) Zink-, blei- und/oder calciumsalze von carbonsaeuren und deren verwendung als korrosionsschutzmittel.
DE69821142D1 (de) Verwendung von prostanoiden-antagonisten zur bhandlung von primären kopfschmerzen
EP0264802A3 (en) Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method
EP0310071A3 (fr) Alpha-aminoacyl aminodiol carbamates non peptidiques comme agents anti-hypertensifs
ES8801629A1 (es) Procedimiento para preparar nuevos derivados de aminoacidos biciclicos
Mel'nikov et al. The Inhibiting Action of Nitrogen-Containing Corrosion Inhibitors in Greases
NZ328482A (en) Using an H2 or H3 agonist to treat sexual dysfunction